Seeking to expand its ophthalmology products business, Alphaeon Corp. will acquire femtosecond laser developer Lensar Inc. for up to $59 million by the end of the year. Founded in 2004 and based in Orlando, Fla., Lensar makes laser systems used in cataract treatment that enable automation of several critical surgical procedure planning and delivering elements. "Lensar has advanced the self-pay category of precision refractive surgery both for ophthalmologists as well as their patients," said Robert E. Grant, CEO of Alphaeon. "The addition of Lensar to our lifestyle product portfolio will provide ophthalmologists with another alternative to expand their offering to patients." Alphaeon is a social commerce company focused on self-pay health care products and services to promote consumer wellness, beauty and performance. For more information, visit www.lensar.com and www.alphaeon.com.